Comparison of surgery rates in biologic-naïve patients with Crohn’s disease treated with vedolizumab or ustekinumab: findings from SOJOURN

BACKGROUND: Crohn’s disease (CD) is a chronic inflammatory bowel disease characterized by relapsing and remitting inflammation that leads to progressive bowel damage. Despite advances in medical treatment for CD, many patients require surgical intervention. Most studies of surgery rates are from pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Michelle, Ghosh, Sabyasachi, Umashankar, Kandavadivu, Weber, Laura, Landis, Christina, Candela, Ninfa, Chastek, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039499/
https://www.ncbi.nlm.nih.gov/pubmed/36966279
http://dx.doi.org/10.1186/s12876-023-02723-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039499/
https://www.ncbi.nlm.nih.gov/pubmed/36966279
http://dx.doi.org/10.1186/s12876-023-02723-5

Ejemplares similares